LONGER-TERM FOLLOW-UP OF A PHASE 1 STUDY OF PONATINIB IN PATIENTS (PTS) WITH PHILADELPHIA CHROMOSOME-POSITIVE (PH plus ) LEUKEMIAS

被引：0
|
作者：
Cortes, J. [1 ]
Talpaz, M. [2 ]
Kantarjian, H. M. [1 ]
Shah, N. P. [3 ]
Bixby, D. [2 ]
Flinn, I. W. [4 ]
O'Hare, T. [5 ]
Hu, S. [6 ]
Rivera, V. [6 ]
Clackson, T. [6 ]
Turner, C. [6 ]
Haluska, F. [6 ]
Druker, B. J. [7 ]
Deininger, M. W. [5 ]
Mauro, M. J. [7 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA
[3] Univ Calif San Francisco, San Francisco, CA 94143 USA
[4] Sarah Cannon Res Inst, Nashville, TN USA
[5] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA
[6] ARIAD Pharmaceut Inc, Cambridge, MA USA
[7] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA
来源：
HAEMATOLOGICA | 2014年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P895
引用
收藏
页码：335 / 335
页数：1
相关论文
共 50 条
  • [21] Efficacy and safety of bosutinib (BOS) for Philadelphia chromosome-positive (Ph plus ) leukemia in older versus younger patients (pts).
    Brummendorf, Tim H.
    Gambacorti-Passerini, Carlo
    Schafhausen, Philippe
    Khoury, Hanna Jean
    Hochhaus, Andreas
    Kindler, Thomas
    Fischer, Thomas
    Besson, Nadine
    Leip, Eric
    Kelly, Virginia
    Cortes, Jorge E.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [22] Updated Results of a Phase II Study of Ponatinib and Blinatumomab for Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
    Short, Nicholas J.
    Kantarjian, Hagop
    Konopleva, Marina
    Desikan, Sai Prasad Prasad
    Jain, Nitin
    Ravandi, Farhad
    Huang, Xuelin
    Wierda, William G.
    Borthakur, Gautam
    Sasaki, Koji
    Issa, Ghayas C.
    Alvarado, Yesid
    Pemmaraju, Naveen
    Garcia-Manero, Guillermo
    DiNardo, Courtney D.
    Thankachan, Jennifer
    Delumpa, Ricardo
    Milton, Anna
    Jabbour, Elias J.
    BLOOD, 2021, 138
  • [23] Long-Term Follow-up of Continuous Imatinib Plus Combination Chemotherapy in Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
    Lim, Sung-Nam
    Lee, Kyoo-Hyung
    Kim, Dae-Young
    Lee, Je-Hwan
    Lee, Jung-Hee
    Chi, Hyun-Sook
    Joo, Young-Don
    Lee, Won Sik
    Lee, Sang Min
    Park, Seonyang
    Kim, Inho
    Sohn, Sang Kyun
    Moon, Joon Ho
    Ryoo, Hun-Mo
    Bae, Sung Hwa
    Kim, Min Kyoung
    Yang, Deok-Hwan
    Eom, Hyeon-Seok
    Lee, Gyeong-Won
    Jung, Chul Won
    Won, Jong-Ho
    Kim, Hawk
    Lee, Jae-Hoon
    Shin, Ho-Jin
    Kim, Ho Young
    Hyun, Myung Soo
    Kim, Hyeoung Joon
    BLOOD, 2014, 124 (21)
  • [24] A phase 2 study of imatinib in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoid leukemias
    Ottmann, OG
    Druker, BJ
    Sawyers, CL
    Goldman, JM
    Reiffers, J
    Silver, RT
    Tura, S
    Fischer, T
    Deininger, MW
    Schiffer, CA
    Baccarani, M
    Gratwohl, A
    Hochhaus, A
    Hoelzer, D
    Fernandes-Reese, S
    Gathmann, I
    Capdeville, R
    O'Brien, SG
    BLOOD, 2002, 100 (06) : 1965 - 1971
  • [25] Frontline Combination of Hyper-CVAD with Ponatinib for Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia-6-Year Follow-up Results
    Nasnas, Patrice
    Jabbour, Elias
    Short, Nicholas
    Sasaki, Koji
    Ravandi, Farhad
    Jain, Nitin
    Daver, Naval
    Pemmaraju, Naveen
    Yilmaz, Musa
    Kadia, Tapan M.
    Garris, Rebecca
    Garcia-Manero, Guillermo
    DiNardo, Courtney D.
    Konopleva, Marina
    Wierda, William G.
    Kwari, Monica
    Loiselle, Christopher
    Milton, Anna
    Rivera, Juan
    Banks, Glenda
    Kantarjian, Hagop
    BLOOD, 2022, 140 : 3250 - 3252
  • [26] Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: long-term follow-up of a single-centre, phase 2 study
    Jabbour, Elias
    Short, Nicholas J.
    Ravandi, Farhad
    Huang, Xuelin
    Daver, Naval
    DiNardo, Courtney D.
    Konopleva, Marina
    Pemmaraju, Naveen
    Wierda, William
    Garcia-Manero, Guillermo
    Sasaki, Koji
    Cortes, Jorge
    Garris, Rebecca
    Khoury, Joseph D.
    Jorgensen, Jeffrey
    Jain, Nitin
    Alvarez, Joie
    O'Brien, Susan
    Kantarjian, Hagop
    LANCET HAEMATOLOGY, 2018, 5 (12): : E618 - E627
  • [27] Interphase FISH for follow-up of Philadelphia chromosome-positive chronic myeloid leukemia treatment
    Douet-Guilbert, N
    Morel, F
    Le Charpentier, T
    Le Bris, MJ
    Herry, A
    Morice, P
    Bourquard, P
    Abgrall, JF
    Berthou, C
    De Braekeleer, M
    ANTICANCER RESEARCH, 2004, 24 (04) : 2535 - 2539
  • [28] Phase II study of combination of hyperCVAD with ponatinib in frontline therapy of patients (pts) with Philadelphia chromosome (Ph) positive acute lymphoblastic leukemia (ALL).
    Jabbour, Elias
    Kantarjian, Hagop M.
    Thomas, Deborah A.
    Ravandi, Farhad
    Cortes, Jorge E.
    Faderl, Stefan
    Pemmaraju, Naveen
    Kadia, Tapan M.
    Garris, Rebecca S.
    Garcia-Manero, Guillermo
    Borthakur, Gautam
    Wierda, William G.
    O'Brien, Susan Mary
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [29] Phase II study of combination of hyperCVAD with ponatinib in frontline therapy of patients (pts) with Philadelphia chromosome (Ph) positive acute lymphoblastic leukemia (ALL).
    O'Brien, Susan Mary
    Jabbour, Elias
    Thomas, Deborah A.
    Ravandi, Farhad
    Cortes, Jorge E.
    Pemmaraju, Naveen
    Kadia, Tapan M.
    Garris, Rebecca
    Jeanis, Vicky
    Garcia-Manero, Guillermo
    Borthakur, Gautam
    Wierda, William G.
    Kantarjian, Hagop M.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [30] CYTOGENETIC FOLLOW-UP OF PATIENTS WITH NONLYMPHOCYTIC LEUKEMIA .1. PHILADELPHIA CHROMOSOME-POSITIVE CHRONIC MYELOID-LEUKEMIA
    HAGEMEIJER, A
    KROEZE, WFS
    ABELS, J
    CANCER GENETICS AND CYTOGENETICS, 1980, 2 (04) : 317 - 326
12345